Hepatitis C virus, the E2 envelope protein, and alpha-interferon resistance.
Abid
K
K
Division of Gastroenterology and Hepatology, University of Geneva Medical School, Geneva, Switzerland.
Quadri
R
R
Negro
F
F
D000595:Amino Acid Sequence; D004352:Drug Resistance, Microbial; D015852:Eukaryotic Initiation Factor-2 / Q000737:chemistry / Q000378:metabolism; D005838:Genotype; D016174:Hepacivirus / Q000187:drug effects* / Q000235:genetics; D006526:Hepatitis C / Q000821:virology; D006801:Humans; D016898:Interferon-alpha / Q000494:pharmacology*; D010766:Phosphorylation; D014759:Viral Envelope Proteins / Q000737:chemistry* / Q000502:physiology*; D019892:eIF-2 Kinase / Q000037:antagonists & inhibitors* / Q000378:metabolism
D015852:Eukaryotic Initiation Factor-2; D016898:Interferon-alpha; D014759:Viral Envelope Proteins; C091015:glycoprotein E2, Hepatitis C virus; D019892:eIF-2 Kinase